News

ASG-5ME Phase I study, expected to recruit about 50 patients at multiple centers in the US, is a single-agent, open-label, dose-escalation study that will assess the safety and

The chemical pharmaceutical factory with latest technologies is said to have good manufacturing practice (GMP), good storage practice (GSP) and good laboratory practice (GLP). VCP is set to

The relationship will allow clients access to both organizations’ core strengths and geographical expertise. The service expansion will be accomplished through mutual referrals, coordinated sales, marketing, and presentation

Roche said that the product is available in Europe as well as in all countries recognising the CE mark in the Latin America and Asia-Pacific regions. According to

Eli Lilly said that the acquisition, initiated on July 2, 2010, has received the approval of Alnara stockholders and clearance under the Hart-Scott-Rodino Antitrust Improvements Act. As per

Mr King is expected to look after clinical operations and site management for Chimerix and Dr Mommeja-Marin will oversee clinical strategy and study design. Both will report to

TPI-287 study includes patients with disease metastatic to the brain as the drug, avoids the multidrug resistant (MDR) efflux pump and has demonstrated in pre-clinical studies its ability

Biomoda’s CyPath reagents for the early detection of cancers is based on meso-tetra (4 carboxyphenyl) porphine (TCPP), a porphyrin compound that binds to cancer cells and fluoresces under

Prolor said that hGH is its proprietary biobetter version of human growth hormone. The Phase II study was commenced to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamic properties